106 related articles for article (PubMed ID: 11514149)
1. Thrombin receptor (PAR-1) antagonists. Solid-phase synthesis of indole-based peptide mimetics by anchoring to a secondary amide.
Zhang HC; McComsey DF; White KB; Addo MF; Andrade-Gordon P; Derian CK; Oksenberg D; Maryanoff BE
Bioorg Med Chem Lett; 2001 Aug; 11(16):2105-9. PubMed ID: 11514149
[TBL] [Abstract][Full Text] [Related]
2. Discovery and optimization of a novel series of thrombin receptor (par-1) antagonists: potent, selective peptide mimetics based on indole and indazole templates.
Zhang HC; Derian CK; Andrade-Gordon P; Hoekstra WJ; McComsey DF; White KB; Poulter BL; Addo MF; Cheung WM; Damiano BP; Oksenberg D; Reynolds EE; Pandey A; Scarborough RM; Maryanoff BE
J Med Chem; 2001 Mar; 44(7):1021-4. PubMed ID: 11297447
[No Abstract] [Full Text] [Related]
3. Synthesis of indole derived protease-activated receptor 4 antagonists and characterization in human platelets.
Young SE; Duvernay MT; Schulte ML; Lindsley CW; Hamm HE
PLoS One; 2013; 8(6):e65528. PubMed ID: 23776495
[TBL] [Abstract][Full Text] [Related]
4. High-affinity thrombin receptor (PAR-1) ligands: a new generation of indole-based peptide mimetic antagonists with a basic amine at the C-terminus.
Zhang HC; White KB; McComsey DF; Addo MF; Andrade-Gordon P; Derian CK; Oksenberg D; Maryanoff BE
Bioorg Med Chem Lett; 2003 Jul; 13(13):2199-203. PubMed ID: 12798334
[TBL] [Abstract][Full Text] [Related]
5. Blockade of the thrombin receptor protease-activated receptor-1 with a small-molecule antagonist prevents thrombus formation and vascular occlusion in nonhuman primates.
Derian CK; Damiano BP; Addo MF; Darrow AL; D'Andrea MR; Nedelman M; Zhang HC; Maryanoff BE; Andrade-Gordon P
J Pharmacol Exp Ther; 2003 Feb; 304(2):855-61. PubMed ID: 12538843
[TBL] [Abstract][Full Text] [Related]
6. Administration of a potent antagonist of protease-activated receptor-1 (PAR-1) attenuates vascular restenosis following balloon angioplasty in rats.
Andrade-Gordon P; Derian CK; Maryanoff BE; Zhang HC; Addo MF; Cheung Wm ; Damiano BP; D'Andrea MR; Darrow AL; de Garavilla L; Eckardt AJ; Giardino EC; Haertlein BJ; McComsey DF
J Pharmacol Exp Ther; 2001 Jul; 298(1):34-42. PubMed ID: 11408522
[TBL] [Abstract][Full Text] [Related]
7. G-protein coupled receptor antagonists-1: protease activated receptor-1 (PAR-1) antagonists as novel cardiovascular therapeutic agents.
Chackalamannil S
Curr Top Med Chem; 2003; 3(10):1115-23. PubMed ID: 12769712
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and biological evaluation of non-peptide PAR1 thrombin receptor antagonists based on small bifunctional templates: arginine and phenylalanine side chain groups are keys for receptor activity.
Androutsou ME; Saifeddine M; Hollenberg MD; Matsoukas J; Agelis G
Amino Acids; 2010 Apr; 38(4):985-90. PubMed ID: 19484400
[TBL] [Abstract][Full Text] [Related]
9. Thrombin receptor (PAR-1) antagonists. Heterocycle-based peptidomimetics of the SFLLR agonist motif.
Hoekstra WJ; Hulshizer BL; McComsey DF; Andrade-Gordon P; Kauffman JA; Addo MF; Oksenberg D; Scarborough RM; Maryanoff BE
Bioorg Med Chem Lett; 1998 Jul; 8(13):1649-54. PubMed ID: 9873407
[TBL] [Abstract][Full Text] [Related]
10. Thrombin receptor antagonists as novel therapeutic targets.
Chackalamannil S
Curr Opin Drug Discov Devel; 2001 Jul; 4(4):417-27. PubMed ID: 11727307
[TBL] [Abstract][Full Text] [Related]
11. Thrombin inhibits NMDA-mediated nociceptive activity in the mouse: possible mediation by endothelin.
Fang M; Kovács KJ; Fisher LL; Larson AA
J Physiol; 2003 Jun; 549(Pt 3):903-17. PubMed ID: 12717003
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of a TRPV1 receptor antagonist.
Yu S; Haight A; Kotecki B; Wang L; Lukin K; Hill DR
J Org Chem; 2009 Dec; 74(24):9539-42. PubMed ID: 19928811
[TBL] [Abstract][Full Text] [Related]
13. Discovery and synthesis of a novel series of quinoline-based thrombin receptor (PAR-1) antagonists.
Clasby MC; Chackalamannil S; Czarniecki M; Doller D; Eagen K; Greenlee WJ; Lin Y; Tsai H; Xia Y; Ahn HS; Agans-Fantuzzi J; Boykow G; Chintala M; Foster C; Bryant M; Lau J
Bioorg Med Chem Lett; 2006 Mar; 16(6):1544-8. PubMed ID: 16380251
[TBL] [Abstract][Full Text] [Related]
14. Discovery and initial structure-activity relationships of trisubstituted ureas as thrombin receptor (PAR-1) antagonists.
Barrow JC; Nantermet PG; Selnick HG; Glass KL; Ngo PL; Young MB; Pellicore JM; Breslin MJ; Hutchinson JH; Freidinger RM; Condra C; Karczewski J; Bednar RA; Gaul SL; Stern A; Gould R; Connolly TM
Bioorg Med Chem Lett; 2001 Oct; 11(20):2691-6. PubMed ID: 11591503
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and structure-activity relationships of novel indazolyl glucocorticoid receptor partial agonists.
Gilmore JL; Sheppeck JE; Wang J; Dhar TG; Cavallaro C; Doweyko AM; Mckay L; Cunningham MD; Habte SF; Nadler SG; Dodd JH; Somerville JE; Barrish JC
Bioorg Med Chem Lett; 2013 Oct; 23(19):5448-51. PubMed ID: 23916594
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the effects of PAR1 antagonists, PAR4 antagonists, and their combinations on thrombin-induced human platelet activation.
Wu CC; Teng CM
Eur J Pharmacol; 2006 Sep; 546(1-3):142-7. PubMed ID: 16890935
[TBL] [Abstract][Full Text] [Related]
17. RWJ-58259: a selective antagonist of protease activated receptor-1.
Damiano BP; Derian CK; Maryanoff BE; Zhang HC; Gordon PA
Cardiovasc Drug Rev; 2003; 21(4):313-26. PubMed ID: 14647534
[TBL] [Abstract][Full Text] [Related]
18. Protease activated receptor 4 (PAR4) antagonists: Research progress on small molecules in the field of antiplatelet agents.
Liu S; Li S; Yuan D; Wang E; Xie R; Zhang W; Kong Y; Zhu X
Eur J Med Chem; 2021 Jan; 209():112893. PubMed ID: 33049608
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and evaluation of urea-based indazoles as melanin-concentrating hormone receptor 1 antagonists for the treatment of obesity.
Souers AJ; Gao J; Wodka D; Judd AS; Mulhern MM; Napier JJ; Brune ME; Bush EN; Brodjian SJ; Dayton BD; Shapiro R; Hernandez LE; Marsh KC; Sham HL; Collins CA; Kym PR
Bioorg Med Chem Lett; 2005 Jun; 15(11):2752-7. PubMed ID: 15911251
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and SAR of 1,3-disubstituted cyclohexylmethyl urea and amide derivatives as non-peptidic motilin receptor antagonists.
Johnson SG; Gunnet JW; Moore JB; Miller W; Wines P; Rivero RA; Combs D; Demarest KT
Bioorg Med Chem Lett; 2006 Jul; 16(13):3362-6. PubMed ID: 16650762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
